Autopsy report · NCT00542594
Survey in Post-menopausal Women Followed up After Treatment With Anastrozole as Adjuvant Therapy
Cause of deathOther
“No results are avaialble as the study did not complete according to the protocol”
Life of this trial
- Registered 1 year 11 months after it had already started.
- Ran for about 5 years 7 months before it stopped.
- 1,840 participants enrolled.
- No results are posted on the registry.
Vital statistics
- Status
- Terminated
- Sponsor
- AstraZeneca
- Sponsor type
- Industry
- Conditions
- Breast Cancer
- Participants
- 1,840
Trials that died the same way
- Phase I/II Study of KRN330 Plus Irinotecan in Patients With Metastatic Colorectal Cancer
“Per protocol, the study was terminated based on interim analysis results” - Pembrolizumab Plus Lenvatinib in Previously Treated Classic Kaposi Sarcoma
“The lack of adequate funding has made it impossible to continue with the clinical study As this study was not initiated, no subject was included and no data was collected,thus no result can be obtained SPONSOR\_DECISION End of trial date:15 Oct 2025” - Study to Compare Different Light Therapies (Narrowband Ultraviolet B vs PUVA) for Hand and Foot Skin Diseases.
“Unfortunately we had unforeseen difficulty recruiting to this study. Therefore we have decided to halt the study and not publish the results.” - Safety, Tolerability, and Pharmacokinetics of AMG 827 in Adolescents With Asthma
“The study had been cancelled and replaced with protocol 20130250.” - Opinions, Perceptions, & Thoughts of British Resident Doctors on Orthopaedics
“Study did not progress past approvals”
Look deeper
- The official registry record (the source of truth)
- Record history: every change the sponsor made
- Open it in the database
Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.